ClinicalTrialsFinder

Clonal Hematopoiesis of Indeterminate Potential Clinical Trials in Shenyang, Liaoning

1 recruitingShenyang, Liaoning, China

Showing 1–1 of 1 trials

Recruiting
Phase 4

Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis

Clonal Hematopoiesis of Indeterminate PotentialColchicineCoronary Atherosclerosis Management
Shenyang Northern Hospital120 enrolled1 locationNCT07362966